Skip to main content Skip to main navigation menu Skip to site footer

Kadar IL-10 plasma berkorelasi positif dengan kadar IgM anti PGL-1 pada narakontak serumah pasien kusta tipe multibasiler

  • Ida Ayu Uttari Priyadarshini ,
  • Nyoman Suryawati ,
  • Luh Made Mas Rusyati ,

Abstract

Introduction: A healthy person who contacts people diagnosed with leprosy can be at a high risk of being infected with leprosy with a predominance of the subclinical stage. The MB type infection has a 4-10 times greater risk of developing into a clinical form. Early detection of subclinical leprosy is important so that it can play a role in the process of eliminating leprosy. If it is not screened, most of the subclinical stage leprosy can develop into the clinical stage and can cause physical deformities. Phenolic glycolipid-1 (PGL-1) is a specific antigen for M.leprae and Interleukin-10 (IL-10) is an anti-inflammatory cytokine that shows the body's immune response. Research on the relationship between levels of IL-10 and IgM anti-PGL-1, especially in Bali, has not been carried out, so this study aims to find a relationship between levels of IL-10 and levels of IgM anti-PGL-1 in household contacts of multibacillary leprosy patients.

Methods: This research is an analytical observational study with a cross-sectional and was carried out in February-May 2021 at the Dermatology and Venereology Polyclinic and Clinical Pathology Laboratory, Sanglah Hospital Denpasar, and the Leprosy reference laboratory, Tropical Diseases Center, Universitas Airlangga. Samples aged 18-65 years were selected through Consecutive Sampling according to inclusion and exclusion criteria. The sample was taken from venous blood and then checked for levels of PGL-1 and IL-10. Data analysis using SPSS version 23. The results were considered significant if p<0.05.

Results: The mean level of IgM anti-PGL-1 in the contact group vs. the non-contact group was 863.07 ± 789.04 u/ml vs 247.75 ± 161.60 u/ml. The mean levels of IL-10 in the contact and non-contact groups were 121.09 ± 144.11 pg/ml and 46.04 ± 11.27 pg/ml. There was a significant difference in levels of IL-10 and IgM anti-PGL-1 in the contact group and non-contact groups (p<0.05) and a weak positive relationship (r=0.296, p=0.02) between levels of IL-10 and anti-PGL-IgM. 1.

Conclusion: The levels of IgM anti-PGL-1 and IL-10 in the contacts were higher than in the non-contacts with a significant difference.

 

Pendahuluan: Narakontak merupakan salah satu kelompok dengan risiko tinggi terinfeksi kusta dengan dominansi stadium subklinis. Pada infeksi tipe MB memiliki resiko 4-10 kali lebih besar berkembang menjadi bentuk klinis. Deteksi dini pada penyakit kusta subklinis ini menjadi penting sehingga dapat berperan dalam proses eliminasi kusta. Jika dibiarkan sebagian besar kusta stadium subklinis dapat berkembang menjadi kusta klinis dan dapat menimbulkan deformitas pada fisik. Phenolic glycolipid-1 (PGL-1) merupakan antigen spesifik untuk M. leprae dan Interleukin-10 (IL-10) merupakan sitokin anti-inflamasi yang menunjukkan respon imun tubuh. Penelitian mengenai hubungan antara kadar IL-10 dan IgM anti PGL-1 khusunya di Bali belum dilakukan, sehingga penelitian ini bertujuan mencari hubungan antara kadar IL-10 dengan kadar IgM anti PGL-1 pada narakontak serumah pasien kusta tipe multibasiler.

Metode: Penelitian merupakan studi observasional analitik dengan pendekatan potong lintang dan dilaksanakan bulan Februari-Mei 2021 di Poliklinik Kulit dan Kelamin dan Laboratorium Patologi Klinik, RSUP Sanglah Denpasar dan laboratorium rujukan Leprosy, Tropical Diseases Centre, Universitas Airlangga. Sampel berusia 18-65 tahun dipilih melalui Consecutive Sampling sesuai kriteria inklusi dan eksklusi. Sampel dilakukan pengambilan darah vena kemudian diperiksa kadar PGL-1 dan IL-10. Analisis data menggunakan SPSS versi 23. Hasil dianggap signifikan jika p<0,05.

Hasil: Rerata kadar IgM anti PGL-1 kelompok narakontak vs bukan narakontak sebesar 863,07 ± 789,04 u/ml vs 247,75 ± 161,60 u/ml. Rerata kadar IL-10 kelompok narakontak dan bukan narakontak sebesar 121,09 ± 144,11 pg/ml dan 46,04 ± 11,27 pg/ml. Terdapat perbedaan signifikan pada kadar IL-10 dan IgM anti PGL-1 pada kelompok narakontak dan bukan narakontak (p<0.05) serta hubungan positif lemah (r=0,296, p=0,02) antara kadar IL-10 dengan IgM anti PGL-1.

Simpulan: Kadar IgM anti PGL-1 dan IL-10 pada narakontak lebih tinggi dari non narakontak dengan perbedaan yang signifikan.

References

  1. Pinho JD, Rivas PMS, Mendes MBP. Presence of Mycobacterium leprae DNA and PGL-1 antigen in household contacts of leprosy patients from a hyperendemic area in Brazil. Genetics and Molecular Research. 2015;14(4):14479-87. doi.org/10.4238/2015.november.18.10.
  2. Goulart IMB, dan Goulart LR. Leprosy: Diagnostic and control challenges for a worldwide disease. Archives of Dermatological Research. 2008;300(6), pp. 269–290. doi: 10.1007/s00403-008-0857-y.
  3. World Health Organization. Global Leprosy Update 2014: Need for Early Case Detection. WHO Weekly Epidemiological Record. 2015;36(90):461-76.
  4. Saraswati PA, Rusyati LMM, Karmila IGAAD. Karakteristik Penderita Kusta Multi Basiller (MB) dengan Reaksi Erythema Nodosum Leprosum (ENL) di Poliklinik Kulit dan Kelamin RSUP Sanglah selama Tahun 2016-2018. Intisari Sains Medis. 2019;10(3):655-658. doi.org/10.15562/ism.v10i3.477
  5. Dinas Kesehatan Propinsi Bali. Profil Kesehatan Propinsi Bali.2015 Diakses dari:www.depkes.go.id/PROPINSI_2015/17_Profil_Kes.Prov.Bali_2015.pdf (diakses tanggal 10 November 2020).
  6. Yudianto, Didik B, Boga H, Titu AS. Pengendalian Penyakit. Dalam: Profil Kesehatan Republik Indonesia Tahun 2014: Jakarta. Kementrian Kesehatan Republik Indonesia. 2015:p. 134-68.
  7. Agusni I, Citrashanty I, Astari L, Prakoeswa CRS, Listiawan MY. Pengobatan pencegahan untuk pemberantasan kusta. Dalam: Prakoeswa CRS, Agusni I, Listiawan MY, editor. Kapita selekta penatalaksanaan morbus hansen terkini. Surabaya: Dept/SMF Ilmu Kesehatan Kulit dan Kelamin. 2013:p. 26-31.
  8. Buhrer-Sekula S. PGL-1 leprosy serology. Rev Soc Bras Med Trop. 2008;41(2): 35. doi.org/10.1590/S0037-86822008000700002.
  9. Girdhar BK. Chemoprophylaxis In: Kar HK, Kumar B. IAL Textbook of Leprosy.1st ed.2010. New Delhi: Jaypee; p418-9.
  10. Sekar B. Bacteriological Aspect. In: Kar H.K., Kumar, B. IAL Texbook of Leprosy. India: Jaypee. 2010:p.87-99.
  11. Modlin RL. 2010. The Innate Immune Response in Leprosy. Curr Opin Immunol. 2010; 22(1):48-54. doi.org/10.1016/j.coi.2009.12.001.
  12. Listiawan M, Savitri D, Susari N, Prakoeswa C, Agusni I, dkk. Hubungan Indeks Bakteri dengan Kadar Antibodi Spesifik pada Pasien Kusta tipe Multibasiler. Berkala Ilmu Penyakit Kulit dan Kelamin. 2005;17(3):218-221.
  13. Moura RS, dan Calado KL. Leprosy serology using PGL-1: A Systematic review. Revista da sociedade bras de med tropical. 2008;41(11):11-18. doi.org/10.1590/s0037-86822008000700004
  14. Leturiondo, A. L., Noronha, A. B., do Nascimento, M., Ferreira, C. O., Rodrigues, F., Moraes, M. O., & Talhari, C. Performance of serological tests PGL1 and NDO-LID in the diagnosis of leprosy in a reference Center in Brazil. BMC infectious diseases.2019;19(1):1-22. https://doi.org/10.1186/s12879-018-3653-0
  15. Buhrer-Sekula S, Smits HL, Gussenhoven GC et al. Simple and fast lateral flow test for classification of leprosy patients and identification of contacts with high risk of developing leprosy. J Clin Microbiol.2003; 41: 1991–1995
  16. Iyer SS, dan Cheng G. Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease. Critical Reviews™ in Immunology.2012;32(1):23-63. https://doi.org/10.1615/critrevimmunol.v32.i1.30
  17. Sutedja EK, Agusni JH, Dharmadji HP. Korelasi Kadar Interleukin-10 dengan Indeks Bakteri pada Pasien Kusta yang Telah Mendapat Pengobatan Multidrug therapy (MDT). Bandung: BIKKK-Periodical of Dermatology and Venereology. 2016;28(1):p. 16-22.
  18. Yamamura M, Uyemura K, Deans RJ. Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science. 1991;254:277-79. doi.org/10.1126/science.254.5029.277
  19. Kodrati A, Salim EM, Hafy Z. Comparison of Serum Interleukin 10 Levels between Leprosy and Non-Leprosy Population. Mutiara Medika: Jurnal Kedokteran dan Kesehatan. 2021;21(1):39-44. doi.org/10.18196/mmjkk.v21i1.6514
  20. Lima MC, Pereira GM, Rumjanek FD, Gomes HM, Duppre N, Sampaio EP, Alvim IM, Nery JA, Sarno EN, Pessolani MC. Immunological cytokine correlates of protective immunity and pathogenesis in leprosy. Scand J Immunol. 2000;51(4):419-28. doi: 10.1046/j.1365-3083.2000.00703.x.
  21. Wang N, Chu T, Li F, Wang Z, Liu D, Chen M, Wang H, Niu G, Liu D, Zhang M, Xu Y, Zhang Y, Li J, Li Z, You J, Mao L, Li H, Chen Y, Liu H, Zhang F. The role of an active surveillance strategy of targeting household and neighborhood contacts related to leprosy cases released from treatment in a low-endemic area of China. PLoS Negl Trop Dis. 2020;14(8):e0008563. doi: 10.1371/journal.pntd.0008563.
  22. Utama YD, Soejoto, Susanto RSD, Indrayanti ES, Subakir, Ernawati D. Kadar Imunoglobulin M Anti Phenolic Glycolipid-I Mycobacterium Leprae dan Tumor Necrosis Factor-α Pada Penderita Lepra Subklinis. Media Medika Indonesiana. 2010; 44(2):pp 83-92.
  23. Rahfiludin MZ, Ginandjar P, Pangestuti DR. Correlation of zink plasma and IgM anti-PGL-1 levels among close contact of leprosy. Med J Indones. 2012;21(3):166-9. https://doi.org/10.13181/mji.v21i3.500
  24. Fukutomi Y, Maeda Y, Matsuoka M, Makino M. Temperature dependency for survival of Mycobacterium leprae in macrophages. Nihon Hansenbyo Gakkai Zasshi. 2009;78(1):7-16. doi: 10.5025/hansen.78.7.
  25. Montoya D, Cruz D, Teles RM, Lee DJ, Ochoa MT, Krutzik SR, Chun R, Schenk M, Zhang X, Ferguson BG, Burdick AE, Sarno EN, Rea TH, Hewison M, Adams JS, Cheng G, Modlin RL. Divergence of macrophage phagocytic and antimicrobial programs in leprosy. Cell Host Microbe. 2009;6(4):343-53. doi: 10.1016/j.chom.2009.09.002.
  26. Antunes DE, Goulart IMB, Lima MIS, Alves PT, Tavares PCB, Goulart LR. Differential Expression of IFN-γ, IL-10, TLR1, and TLR2 and Their Potential Effects on Downgrading Leprosy Reaction and Erythema Nodosum Leprosum. J Immunol Res. 2019;2019:3405103. doi: 10.1155/2019/3405103.
  27. Manca C, Peixoto B, Malaga W, Guilhot C, Kaplan G. Modulation of the cytokine response in human monocytes by mycobacterium leprae phenolic glycolipid-1. J Interferon Cytokine Res. 2012;32(1):27-33. doi:10.1089/jir.2011.0044
  28. Alvarado-Arnez LE, Amaral EP, Sales-Marques C, Durães SMB, Cardoso CC, Sarno EN, Pacheco AG, Lana FCF, Mora MO. Association of IL10 polymorphisms and leprosy: A meta-analysis. PLoS ONE. 2015;10(9):p.1–13. https://doi.org/10.1371/journal.pone.0136282
  29. Moura DF, de Mattos KA, Amadeu TP, Andrade PR, Sales JS, Schmitz V, Nery JA, Pinheiro RO, Sarno EN. CD163 favors Mycobacterium leprae survival and persistence by promoting anti-inflammatory pathways in lepromatous macrophages. Eur J Immunol. 2012;42(11):2925-36. doi: 10.1002/eji.201142198.
  30. Tarique M, Naz H, Saini C, Suhail M, Shankar H, Khanna N, Sharma A. Association of IL-10 Gene Polymorphism With IL-10 Secretion by CD4 and T Regulatory Cells in Human Leprosy. Front Immunol. 2020;11:1974. doi: 10.3389/fimmu.2020.01974.
  31. van Hooij A, Tió-Coma M, Verhard EM, Khatun M, Alam K, Tjon Kon Fat E, de Jong D, Sufian Chowdhury A, Corstjens P, Richardus JH, Geluk A. Household Contacts of Leprosy Patients in Endemic Areas Display a Specific Innate Immunity Profile. Front Immunol. 2020;11:1811. doi: 10.3389/fimmu.2020.01811.
  32. Sales AM, Ponce de Leon A, Düppre NC, Hacker MA, Nery JA, Sarno EN, Penna ML. Leprosy among patient contacts: a multilevel study of risk factors. PLoS Negl Trop Dis. 2011 Mar 15;5(3):e1013. doi: 10.1371/journal.pntd.0001013.
  33. Quilter EEV, Butlin CR, Singh S, Alam K, Lockwood DNJ. Patients with skin smear positive leprosy in Bangladesh are the main risk factor for leprosy development: 21-year follow-up in the household contact study (COCOA). PLoS Negl Trop Dis. 2020;14(10):e0008687. doi:10.1371/journal.pntd.0008687
  34. Douglas JT, Cellona RV, Fajardo TT Jr, Abalos RM, Balagon MV, Klatser PR. Prospective study of serological conversion as a risk factor for development of leprosy among household contacts. Clin Diagn Lab Immunol. 2004;11(5):897-900. doi: 10.1128/CDLI.11.5.897-900.2004.

How to Cite

Priyadarshini, I. A. U., Nyoman Suryawati, & Luh Made Mas Rusyati. (2022). Kadar IL-10 plasma berkorelasi positif dengan kadar IgM anti PGL-1 pada narakontak serumah pasien kusta tipe multibasiler. Intisari Sains Medis, 13(1), 243–250. https://doi.org/10.15562/ism.v13i1.1334

HTML
0

Total
0

Share

Search Panel

Ida Ayu Uttari Priyadarshini
Google Scholar
Pubmed
ISM Journal


Nyoman Suryawati
Google Scholar
Pubmed
ISM Journal


Luh Made Mas Rusyati
Google Scholar
Pubmed
ISM Journal